-
Phenotyping of animal models of rare diseases with visual disability
2020
Senior Researcher : Lluís Montoliu José
Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
more information
on Phenotyping of animal models of rare diseases with visual disability
-
The neuronal glycine transporter GlyT2 in herplexia: a glycinergic pathology of development
2020
Senior Researcher : Beatriz López Corcuera
Research Centre or Institution : Centro de Biología Molecular Severo Ochoa. CSIC - UAM
more information
on The neuronal glycine transporter GlyT2 in herplexia: a glycinergic pathology of development
-
Serum markers in patients with congenital melanocytic nevi: clinicopathological and genetic correlation
2020
Senior Researcher : Pedro Redondo Bellón
Research Centre or Institution : Clínica Universidad de Navarra. Pamplona
more information
on Serum markers in patients with congenital melanocytic nevi: clinicopathological and genetic correlation
-
Propionic acidemia: impact on the epigenome and the proteome in relation to the cardiac and neurological phenotype
2020
Senior Researcher : Eva María Richard Rodríguez
Research Centre or Institution : Centro de Biología Molecular Severo Ochoa. CSIC - UAM
more information
on Propionic acidemia: impact on the epigenome and the proteome in relation to the cardiac and neurological phenotype
-
Characterization of macromolecular targets as a key to understanding, diagnosis and design of therapies in rare diseases
2020
Senior Researcher : Vicente Rubio Zamora
Research Centre or Institution : Instituto de Biomedicina de Valencia. CSIC.
more information
on Characterization of macromolecular targets as a key to understanding, diagnosis and design of therapies in rare diseases
-
Dissecting a neuron-to-liver crosstalk to modulate lipid metabolism in Batten disease
2018
Senior Researcher : Juan Pedro Bolaños Hernández
Research Centre or Institution : Instituto de Biología Funcional y Genómica, Universidad de Salamanca-CSIC
more information
on Dissecting a neuron-to-liver crosstalk to modulate lipid metabolism in Batten disease
-
Gene therapy to correct glutaric aciduria type 1 in Gcdh -1- mice
2018
Senior Researcher : Cristina Fillat Fonts
Research Centre or Institution : Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS). Barcelona.
more information
on Gene therapy to correct glutaric aciduria type 1 in Gcdh -1- mice
-
Systems medicine applied to the identification of new therapeutic targets in rare genetic-based diseases
2018
Senior Researcher : Juan Antonio García Ranea
Research Centre or Institution : CIBERER. Universidad de Málaga
more information
on Systems medicine applied to the identification of new therapeutic targets in rare genetic-based diseases
-
Advanced gene editing technologies to restore LAMA2 on merosin-deficient congenital muscular dystrophy type 1A
2018
Senior Researcher : Marc Güell Cargol
Research Centre or Institution : Universidad Pompeu Fabra. Barcelona
more information
on Advanced gene editing technologies to restore LAMA2 on merosin-deficient congenital muscular dystrophy type 1A
-
Molecular mechanisms underlying Zic2-associated holoprosencephaly
2018
Senior Researcher : Eloisa Herrera González de Molina
Research Centre or Institution : Instituto de Neurociencias. CSIC-Universidad Miguel Hernández. Alicante.
more information
on Molecular mechanisms underlying Zic2-associated holoprosencephaly
-
New insights on Aicardi-Goutieres Syndrome, a novel connection with DNA repair
2018
Senior Researcher : Pablo Huertas Sánchez
Research Centre or Institution : Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER)
more information
on New insights on Aicardi-Goutieres Syndrome, a novel connection with DNA repair
-
Artificial intelligence and machine learning in human diseases
2018
Senior Researcher : Pablo Lapunzina Badía
Research Centre or Institution : INGEMM-Hospital Universitario La Paz-CIBERER. Madrid
more information
on Artificial intelligence and machine learning in human diseases
-
Novel immunotherapeutic strategies against T-ALL, a rare pediatric disease
2018
Senior Researcher : María Luisa Toribio García
Research Centre or Institution : Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
more information
on Novel immunotherapeutic strategies against T-ALL, a rare pediatric disease
-
Therapeutic strategy against Huntington's disease through the synergistic activation of AMPK
2018
Senior Researcher : Rafael Vázquez Manrique
Research Centre or Institution : Instituto de Investigación Sanitaria La Fe. Valencia
more information
on Therapeutic strategy against Huntington's disease through the synergistic activation of AMPK
-
Molecular mechanisms in the development of scoliosis in limb-girdle muscular dystrophies
2018
Senior Researcher : Juan Viña Ribes
Research Centre or Institution : Universidad de Valencia.
more information
on Molecular mechanisms in the development of scoliosis in limb-girdle muscular dystrophies
-
The function of the E3 ubiquitin ligase APC/C-Cdh1 in Fragile X Syndrome. Possible therapeutic application
2016
Senior Researcher : Ángeles Almeida Parra
Research Centre or Institution : Instituto de Investigación Biomédica de Salamanca (IBSAL). CSIC-Universidad de Salamanca.
more information
on The function of the E3 ubiquitin ligase APC/C-Cdh1 in Fragile X Syndrome. Possible therapeutic application
-
A knowledge-based pipeline to increase the diagnosis rate of Rare Diseases using deep sequencing
2016
Senior Researcher : Carmen Ayuso García
Research Centre or Institution : Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM). CIBERER. Madrid.
more information
on A knowledge-based pipeline to increase the diagnosis rate of Rare Diseases using deep sequencing
-
Systemic analysis of the gene regulatory networks involved in the specification and maintenance of the retinal pigment epithelium: towards new therapies for retinal degenerative diseases
2016
Senior Researcher : Paola Bovolenta Nicolao
Research Centre or Institution : Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
more information
on Systemic analysis of the gene regulatory networks involved in the specification and maintenance of the retinal pigment epithelium: towards new therapies for retinal degenerative diseases
-
Dyskeratosis congenita. New models, New molecular keys and New treatments
2016
Senior Researcher : María Luisa Cayuela Fuentes
Research Centre or Institution : Hospital Clínico Universitario Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca. El Palmar, Murcia.
more information
on Dyskeratosis congenita. New models, New molecular keys and New treatments
-
Molecular basis of immune deficiency in Wolf-Hirschhorn Syndrome (4p-)
2016
Investigador Principal: César Cobaleda Hernández
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Molecular basis of immune deficiency in Wolf-Hirschhorn Syndrome (4p-)
-
Visualisation of neuronal polysomal architecture and its alterations in Huntington's Disease
2016
Investigador Principal: José Jesús Fernández Rodríguez
Centro de investigación o Institución: Centro Nacional de Biotecnología (CNB). CSIC. Madrid
más información
sobre Visualisation of neuronal polysomal architecture and its alterations in Huntington's Disease
-
Modeling of familial cerebral cavernous malformation through cellular reprogramming
2016
Investigador Principal: Miguel Ángel Fidalgo Pérez
Centro de investigación o Institución: Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS). Universidad de Santiago de Compostela
más información
sobre Modeling of familial cerebral cavernous malformation through cellular reprogramming
-
Phosphodiesterase inhibitors as Friedreich's ataxia treatment
2016
Investigador Principal: Pilar González Cabo
Centro de investigación o Institución: Centro de Investigación Biomédica en Red (CIBER de Enfermedades Raras). Facultad de Medicina y Odontología. Universidad de Valencia
más información
sobre Phosphodiesterase inhibitors as Friedreich's ataxia treatment
-
Activation of innate immunity in dysferlin-deficient cells: new therapeutic targets
2016
Investigador Principal: Noemí de Luna Salvà
más información
sobre Activation of innate immunity in dysferlin-deficient cells: new therapeutic targets
-
The connection between rare diseases and common diseases: dysfunction of copper homeostasis and mitochondria as a model (NeuroCopper)
2016
Investigador Principal: Francesc Palau Martínez
Centro de investigación o Institución: Instituto de Investigación Sanitaria Sant Joan de Déu y Hospital Sant Joan de Déu. Barcelona.
más información
sobre The connection between rare diseases and common diseases: dysfunction of copper homeostasis and mitochondria as a model (NeuroCopper)
-
Towards the improvement of diagnosis and treatment in Congenital Dyserythropoyetic Anaemias
2016
Investigador Principal: María del Carmen Sánchez Fernández
Centro de investigación o Institución: Instituto de Investigación contra la Leucemia Josep Carreras (IJC). Barcelona.
más información
sobre Towards the improvement of diagnosis and treatment in Congenital Dyserythropoyetic Anaemias
-
Astrocytes: new anti-epileptic targets in Lafora disease
2016
Investigador Principal: Pascual Felipe Sanz Bigorra
más información
sobre Astrocytes: new anti-epileptic targets in Lafora disease
-
AGC1 deficiency and calcium signaling in mitochondria: a new disease model for the study of pathogenic mechanisms and for the development of therapeutic strategies
2016
Investigador Principal: Jorgina Satrústegui Gil-Delgado
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre AGC1 deficiency and calcium signaling in mitochondria: a new disease model for the study of pathogenic mechanisms and for the development of therapeutic strategies
-
Tracing tissue damage and the adaptive response in rare hereditary haemochromatosis for the identification of specific therapeutic targets
2014
Investigador Principal: José Manuel Bautista Santa Cruz
Centro de investigación o Institución: Instituto de Investigación Hospital 2 de Octubre. Madrid.
más información
sobre Tracing tissue damage and the adaptive response in rare hereditary haemochromatosis for the identification of specific therapeutic targets
-
Cellular response to blocked breakages of DNA and its role in the pathogenesis of Ataxia-Telangiectasia
2014
Investigador Principal: Felipe Cortés Ledesma
Centro de investigación o Institución: Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER)
más información
sobre Cellular response to blocked breakages of DNA and its role in the pathogenesis of Ataxia-Telangiectasia
-
Characterisation of MORC2, a new gene involved in peripheral neuropathies
2014
Investigador Principal: Carmen Espinós Armero
Centro de investigación o Institución: Centro de Investigación Príncipe Felipe
más información
sobre Characterisation of MORC2, a new gene involved in peripheral neuropathies
-
Molecular therapy for Laminopathies
2014
Investigador Principal: Ana María González García
Centro de investigación o Institución: Centro Nacional de Biotecnología (CNB). CSIC. Madrid
más información
sobre Molecular therapy for Laminopathies
-
New mechanisms for regulating the immune response for lamin A/C and progerine: implications in Hutchinson-Gilford premature ageing síndrome
2014
Investigador Principal: José María González-Granado
Centro de investigación o Institución: Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid
más información
sobre New mechanisms for regulating the immune response for lamin A/C and progerine: implications in Hutchinson-Gilford premature ageing síndrome
-
Models for congenital muscular dystrophies: the search for phenotype suppressors
2014
Investigador Principal: Enrique Martín Blanco
Centro de investigación o Institución: Instituto de Biología Molecular de Barcelona. CSIC.
más información
sobre Models for congenital muscular dystrophies: the search for phenotype suppressors
-
Identification of the function of the Wt1gene in Huntington's disease
2014
Investigador Principal: Ofelia M. Martínez Estrada
Centro de investigación o Institución: Departamento de Biología Celular. Universidad de Barcelona
más información
sobre Identification of the function of the Wt1gene in Huntington's disease
-
Propionic acidemia: a study which has the aim of optimising its nutritional treatment, metabolic control and quality of life
2014
Investigador Principal: Mercedes Martínez-Pardo Casanova
Centro de investigación o Institución: CSUR (Centro de Referencia Nacional) de Enfermedades Metabólicas poco frecuentes. Hospital Universitario Ramón y Cajal (Madrid)
más información
sobre Propionic acidemia: a study which has the aim of optimising its nutritional treatment, metabolic control and quality of life
-
Study of the molecular bases of hereditary blindness
2014
Investigador Principal: Ana Méndez Zunzunegui
Centro de investigación o Institución: Instituto de Investigación Biomédica de Bellvitge (IDIBELL). Barcelona.
más información
sobre Study of the molecular bases of hereditary blindness
-
Agenesis of the corpus callosum. Basic mechanisms and treatment
2014
Investigador Principal: Marta Nieto López
Centro de investigación o Institución: Centro Nacional de Biotecnología (CNB). CSIC. Madrid
más información
sobre Agenesis of the corpus callosum. Basic mechanisms and treatment
-
Precision medicine in Primary Immunodeficiencies: deciphering new genetic etiologies by means of "omic" approaches
2014
Investigador Principal: Rebeca Pérez de Diego
Centro de investigación o Institución: IdiPAZ, Instituto de Investigación Sanitaria del Hospital Universitario La Paz. Madrid.
más información
sobre Precision medicine in Primary Immunodeficiencies: deciphering new genetic etiologies by means of "omic" approaches
-
The nuclear lamin in Huntington's disease: its role in the pathology and therapeutic applications
2014
Investigador Principal: Esther Pérez-Navarro
Centro de investigación o Institución: Universidad de Barcelona.
más información
sobre The nuclear lamin in Huntington's disease: its role in the pathology and therapeutic applications
-
Genome and transcriptome analysis to identify splicing defects and in vivo evaluation of antisense therapy
2014
Investigador Principal: Lourdes Ruiz Desviat
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Genome and transcriptome analysis to identify splicing defects and in vivo evaluation of antisense therapy
-
Molecular mechanisms in Dravet's syndrome
2014
Investigador Principal: Francisco Zafra Gómez
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Molecular mechanisms in Dravet's syndrome
-
The complete sequencing of the exomic genome of systemic lupus erythematosus in families of European origin with multiple cases: the identification of rare mutations and their functional consequences
2011
Investigador Principal: Marta Eugenia Alarcón Riquelme
Centro de investigación o Institución: Centro Pfizer. Universidad de Granada. Junta de Andalucía de Genómica e Investigación Oncológica (GENYO). Granada
más información
sobre The complete sequencing of the exomic genome of systemic lupus erythematosus in families of European origin with multiple cases: the identification of rare mutations and their functional consequences
-
The identification of new genes responsible for Hereditary Dystrophies of the Retina using Next-Generation Sequencing technology and the determination of associated pathogenic mechanisms
2011
Investigador Principal: Guillermo Antiñolo Gil
Centro de investigación o Institución: Hospital Universitario Virgen del Rocío. Sevilla.
más información
sobre The identification of new genes responsible for Hereditary Dystrophies of the Retina using Next-Generation Sequencing technology and the determination of associated pathogenic mechanisms
-
Chronic activation of the TGF‑beta route in Marfan's syndrome: deregulation of intracellular traffic and the extracellular matrix
2011
Investigador Principal: Gustavo Egea Guri
Centro de investigación o Institución: Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS). Barcelona.
más información
sobre Chronic activation of the TGF‑beta route in Marfan's syndrome: deregulation of intracellular traffic and the extracellular matrix
-
The transplant of bioengineered skin for cutaneous regeneration in patients with Dystrophic Epidermolysis Bullosa
2011
Investigador Principal: María José Escámez Toledano
Centro de investigación o Institución: Universidad Carlos III de Madrid.
más información
sobre The transplant of bioengineered skin for cutaneous regeneration in patients with Dystrophic Epidermolysis Bullosa
-
The correction of fibroblasts with mutations causing Wiskott Aldrich syndrome by means of adeno-associated viruses (AAV). The effects of corrective methods on cellular reprogramming by means of episomal vectors
2011
Investigador Principal: Miguel Ángel de la Fuente García
Centro de investigación o Institución: Instituto de Biología y Genética Molecular (IBGM).Valladolid.
más información
sobre The correction of fibroblasts with mutations causing Wiskott Aldrich syndrome by means of adeno-associated viruses (AAV). The effects of corrective methods on cellular reprogramming by means of episomal vectors
-
The identification of genetic factors predicting for clonal progression in Systemic Mastocytosis
2011
Investigador Principal: Andrés Celestino García Montero
Centro de investigación o Institución: Instituto de Biología Molecular y Celular del Cáncer. Universidad de Salamanca-CSIC.
más información
sobre The identification of genetic factors predicting for clonal progression in Systemic Mastocytosis
-
Modification of the folding and function of mutated opsins by cellular factors as a new therapeutic strategy for degenerative diseases of the retina
2011
Investigador Principal: Pere Garriga Solé
Centro de investigación o Institución: Universidad Politécnica de Cataluña. Barcelona.
más información
sobre Modification of the folding and function of mutated opsins by cellular factors as a new therapeutic strategy for degenerative diseases of the retina
-
Cdk5: a therapeutic target for the treatment of motor and cognitive deficits in Huntington's disease
2011
Investigador Principal: Silvia Ginés Padrós
Centro de investigación o Institución: Universidad de Barcelona.
más información
sobre Cdk5: a therapeutic target for the treatment of motor and cognitive deficits in Huntington's disease
-
Modulation of the pathological accumulation of glycogen: therapeutic target for the treatment of Glycogenosis
2011
Investigador Principal: Joan J. Guinovart Cirera
Centro de investigación o Institución: Instituto de Investigación Biomédica (IRB) Barcelona.
más información
sobre Modulation of the pathological accumulation of glycogen: therapeutic target for the treatment of Glycogenosis
-
Directed neuronal differentiation of stem-like glioma initiating cells
2011
Investigador Principal: Núria de la Iglesia Zaragoza
Centro de investigación o Institución: Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS). Barcelona.
más información
sobre Directed neuronal differentiation of stem-like glioma initiating cells
-
Analysis of the contribution of CRB2 protein to the establishment and permanence of adherent joins in the pigmentary epithelium, and its relationship with retinal dystrophies
2011
Investigador Principal: Mª Concepción Lillo Delgado
Centro de investigación o Institución: Instituto de Neurociencias de Castilla y León. Universidad de Salamanca.
más información
sobre Analysis of the contribution of CRB2 protein to the establishment and permanence of adherent joins in the pigmentary epithelium, and its relationship with retinal dystrophies
-
Molecular mechanisms, experimental models and therapeutic approaches in Frontotemporal Lobe Dementia (DLFT-TDP)
2011
Investigador Principal: Ángeles Martín Requero
Centro de investigación o Institución: Centro de Investigaciones Biológicas (CSIC)
más información
sobre Molecular mechanisms, experimental models and therapeutic approaches in Frontotemporal Lobe Dementia (DLFT-TDP)
-
The development of molecular scalpels for the repair of genes involved in single gene diseases
2011
Investigador Principal: Guillermo Montoya Blanco
Centro de investigación o Institución: Centro Nacional de Investigaciones Oncológicas (CNIO). Madrid
más información
sobre The development of molecular scalpels for the repair of genes involved in single gene diseases
-
Dominant autosomal sensorineural hypoacusis: expansion of molecular diagnosis by applying new technologies, undertaking functional analysis and creating murine models
2011
Investigador Principal: Miguel Ángel Moreno Pelayo
Centro de investigación o Institución: Hospital Universitario Ramón y Cajal, IRYCIS. Madrid.
más información
sobre Dominant autosomal sensorineural hypoacusis: expansion of molecular diagnosis by applying new technologies, undertaking functional analysis and creating murine models
-
Allan-Herndon-Dudley syndrome: molecular mechanisms and a therapeutic approach in the murine model of the disease
2011
Investigador Principal: Beatriz Morte Molina
Centro de investigación o Institución: Centros de Investigación Biomédica en Red (CIBER). Madrid
más información
sobre Allan-Herndon-Dudley syndrome: molecular mechanisms and a therapeutic approach in the murine model of the disease
-
Pathological mechanisms in Lysinuria with protein intolerance
2011
Investigador Principal: Manuel Palacín Prieto
Centro de investigación o Institución: Instituto de Investigación Biomédica (IRB) Barcelona.
más información
sobre Pathological mechanisms in Lysinuria with protein intolerance
-
Study of the functional implications of GRK2 serine-threonine kinase in Hereditary Haemorrhagic Telangiectasia
2011
Investigador Principal: Petronila Penela Márquez
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Study of the functional implications of GRK2 serine-threonine kinase in Hereditary Haemorrhagic Telangiectasia
-
Hereditary metabolic diseases: searching for new genes that cause diseases and research into new therapeutic strategies
2011
Investigador Principal: Mª del Pilar Rodríguez Pombo
Centro de investigación o Institución: Universidad Autónoma de Madrid.
más información
sobre Hereditary metabolic diseases: searching for new genes that cause diseases and research into new therapeutic strategies
-
Translational Research into rare diseases of iron metabolism using massive parallel sequencing
2011
Investigador Principal: Mª del Carmen Sánchez Fernández
Centro de investigación o Institución: Instituto de Medicina Predictiva y Personalizada del Cáncer. Barcelona.
más información
sobre Translational Research into rare diseases of iron metabolism using massive parallel sequencing
-
Study of the role of PSGL-1 in the control of the development of autoimmune diseases
2011
Investigador Principal: Ana Carmen Urzainqui Mayayo
Centro de investigación o Institución: Hospital Universitario de la Princesa. Madrid.
más información
sobre Study of the role of PSGL-1 in the control of the development of autoimmune diseases
-
Clinical and molecular genetics study of recessive autosomal congenital icthyosis in Spain
2011
Investigador Principal: Ana Vega Gliemmo
Centro de investigación o Institución: Fundación Pública Gallega de Medicina Genómica. Santiago de Compostela.
más información
sobre Clinical and molecular genetics study of recessive autosomal congenital icthyosis in Spain
-
The molecular bases for variability in the presentation and clinical development of Wilson's disease
2011
Investigador Principal: Ignacio Vicente-Sandoval
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre The molecular bases for variability in the presentation and clinical development of Wilson's disease
-
New therapeutic targets for myotonic dystrophy: analysis of microRNAs in two animal models of the disease
2008
Investigador Principal: Rubén Darío Artero Allepuz
Centro de investigación o Institución: Facultad de Biología. Universidad de Valencia
más información
sobre New therapeutic targets for myotonic dystrophy: analysis of microRNAs in two animal models of the disease
-
Molecular genetic study of recessive hereditary autosomal hearing loss, linked to X chromosome and maternal mitochondria
2008
Investigador Principal: Ignacio del Castillo Fernández del Pino
Centro de investigación o Institución: Hospital Universitario Ramón y Cajal. Madrid.
más información
sobre Molecular genetic study of recessive hereditary autosomal hearing loss, linked to X chromosome and maternal mitochondria
-
Study of the possible immunomodulation caused by Anisakis simplex larval antigens
2008
Investigador Principal: María del Carmen Cuéllar del Hoyo
Centro de investigación o Institución: Facultad de Farmacia. Universidad Complutense. Madrid
más información
sobre Study of the possible immunomodulation caused by Anisakis simplex larval antigens
-
Type Gaucher's Disease. Phenotypic variability of bone disorders and their study using techniques of genomics, transcriptomics and proteomics
2008
Investigador Principal: Francisco España Furió
Centro de investigación o Institución: Hospital Universitario La Fe. Valencia.
más información
sobre Type Gaucher's Disease. Phenotypic variability of bone disorders and their study using techniques of genomics, transcriptomics and proteomics
-
Molecular and cellular bases of mental retardation associated with "Fragile X" syndrome
2008
Investigador Principal: José Antonio Esteban García
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Molecular and cellular bases of mental retardation associated with "Fragile X" syndrome
-
Alternative therapies for inherited metabolic diseases
2008
Investigador Principal: Alejandra Gámez Abascal
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Alternative therapies for inherited metabolic diseases
-
Towards a complete model of the molecular network disrupted in Fanconi anaemia
2008
Investigador Principal: Miguel Ángel Genestar Pujana
Centro de investigación o Institución: Instituto Catalán de Oncología. Instituto de Investigación Biomédica de Bellvitge (IDIBELL). Barcelona.
más información
sobre Towards a complete model of the molecular network disrupted in Fanconi anaemia
-
Involvement of Ras oncogenes in the development of Costello and Noonan syndromes
2008
Investigador Principal: Carmen Guerra González
Centro de investigación o Institución: Centro Nacional de Investigaciones Oncológicas (CNIO). Madrid
más información
sobre Involvement of Ras oncogenes in the development of Costello and Noonan syndromes
-
Analysis using genetically modified mice of the possible role of alpha-synuclein in the pathogenesis of Huntington's disease
2008
Investigador Principal: José Javier Lucas Lozano
Centro de investigación o Institución: Centro de Biología Molecular "Severo Ochoa". CSIC-Universidad Autónoma de Madrid
más información
sobre Analysis using genetically modified mice of the possible role of alpha-synuclein in the pathogenesis of Huntington's disease
-
Structural approach to the molecular basis of two rare kidney diseases
2008
Investigador Principal: Óscar Llorca Blanco
Centro de investigación o Institución: Centro de Investigaciones Biológicas (CSIC)
más información
sobre Structural approach to the molecular basis of two rare kidney diseases
-
Genetic and cellular basis of 16p11.2-p12.2 microdeletion syndrome and related neural disorders
2008
Investigador Principal: Marcos Malumbres Martínez
Centro de investigación o Institución: Centro Nacional de Investigaciones Oncológicas (CNIO). Madrid
más información
sobre Genetic and cellular basis of 16p11.2-p12.2 microdeletion syndrome and related neural disorders
-
Molecular basis of congenital erythropoietic porphyria. In vivo stability studies of uroporphyrinogen III synthase
2008
Investigador Principal: Óscar Millet Aguilar-Galindo
Centro de investigación o Institución: Unidad de Biología Estructural. Centro de Investigación Cooperativa en Biociencias (CICbioGUNE). Vizcaya.
más información
sobre Molecular basis of congenital erythropoietic porphyria. In vivo stability studies of uroporphyrinogen III synthase
-
Development of a vaccine against Fasciola hepatica based on the use of bioinformatics tools
2008
Investigador Principal: Antonio Muro Álvarez
Centro de investigación o Institución: Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS)
más información
sobre Development of a vaccine against Fasciola hepatica based on the use of bioinformatics tools
-
Sp2-iminosugars as chemical chaperones: a general strategy for the treatment of lysosomal storage disorders
2008
Investigador Principal: Carmen Ortiz Mellet
Centro de investigación o Institución: Facultad de Química. Universidad de Sevilla
más información
sobre Sp2-iminosugars as chemical chaperones: a general strategy for the treatment of lysosomal storage disorders
-
Development of a therapy for the treatment of congenital dyskeratosis, X-linked Werner syndrome and aplastic anaemia based on the reactivation of telomerase activity by an internal fragment of dyskerin
2008
Investigador Principal: Rosario Perona Abellón
Centro de investigación o Institución: Instituto de Investigaciones Biomédicas de Madrid. CSIC-UAM.
más información
sobre Development of a therapy for the treatment of congenital dyskeratosis, X-linked Werner syndrome and aplastic anaemia based on the reactivation of telomerase activity by an internal fragment of dyskerin
-
Contributions of aquaporins and transduction proteins in the treatment of achondroplasia
2008
Investigador Principal: Jesús Pintor Just
Centro de investigación o Institución: Escuela Universitaria de Óptica. Universidad Complutense. Madrid
más información
sobre Contributions of aquaporins and transduction proteins in the treatment of achondroplasia
-
Characterisation of the autoantigen epitope in Goodpasture syndrome using phage display technology
2008
Investigador Principal: Jesús Rodríguez Díaz
Centro de investigación o Institución: Instituto de Agroquímica y Tecnología deAlimentos(IATA). CSIC. Valencia. (Spain).
más información
sobre Characterisation of the autoantigen epitope in Goodpasture syndrome using phage display technology
-
Effect of the oleic acid neurotrophic factor in an animal model of Down syndrome. Implications for central nervous system development
2008
Investigador Principal: Ana Velasco Criado
Centro de investigación o Institución: Instituto de Neurociencias de Castilla y León. Universidad de Salamanca.
más información
sobre Effect of the oleic acid neurotrophic factor in an animal model of Down syndrome. Implications for central nervous system development
-
Study of the regulation of protein PSTPIP1 via tyrosine phosphorylation and its contribution to the aetiology of the PAPA autoinflammatory disease
2008
Investigador Principal: Andrés Alonso García
Centro de investigación o Institución: Instituto de Biología y Genética Molecular. CSIC. Valladolid.
más información
sobre Study of the regulation of protein PSTPIP1 via tyrosine phosphorylation and its contribution to the aetiology of the PAPA autoinflammatory disease
-
Detection of molecules related to the mechanism of protection against canine Leishmaniasis. Differential gene expression in cells activated during the protection response induced by the LACK vaccine
2008
Investigador Principal: Vicente Emilio Larraga Rodríguez de Vera
Centro de investigación o Institución: Centro de Investigaciones Biológicas (CSIC)
más información
sobre Detection of molecules related to the mechanism of protection against canine Leishmaniasis. Differential gene expression in cells activated during the protection response induced by the LACK vaccine
-
Therapeutic trials in cells from patients suffering hereditary haemorrhagic telangiectasis (HHT) and cell gene therapy employing endothelial progenitor cells in an HHT murine model
2006
Investigador Principal: Luisa María Botella Cubells
Centro de investigación o Institución: Centro de Investigaciones Biológicas (CSIC)
más información
sobre Therapeutic trials in cells from patients suffering hereditary haemorrhagic telangiectasis (HHT) and cell gene therapy employing endothelial progenitor cells in an HHT murine model
-
Characterisation of the astrocytic function in megalencephalic leukoencephalopathy
2006
Investigador Principal: Raúl Estévez Povedano
Centro de investigación o Institución: Instituto de Investigaciones Biomédicas de Bellvitge-Universidad de Barcelona.
más información
sobre Characterisation of the astrocytic function in megalencephalic leukoencephalopathy
-
Neurobiological foundations of and genetic susceptibility to fibromyalgia
2006
Investigador Principal: Manuel J. López Pérez
Centro de investigación o Institución: Facultad de Veterinaria. Universidad de Zaragoza
más información
sobre Neurobiological foundations of and genetic susceptibility to fibromyalgia
-
Integration and modelling of the metabolism and biological effects of the biogenic amines, biomolecules directly involved in rare and emerging diseases
2006
Investigador Principal: Miguel Ángel Medina Torres
Centro de investigación o Institución: Facultad de Ciencias. Universidad de Málaga
más información
sobre Integration and modelling of the metabolism and biological effects of the biogenic amines, biomolecules directly involved in rare and emerging diseases
-
Characterisation and study of the implications of copy number variations in patients with X chromosome-related mental retardation
2006
Investigador Principal: Montserrat Milà Recasens
Centro de investigación o Institución: Fundació Clínic per a la Recerca Biomèdica. Hospital Clínic. Barcelona
más información
sobre Characterisation and study of the implications of copy number variations in patients with X chromosome-related mental retardation
-
Dendritic alterations in Down's Syndrome: the role of the pathway regulating local mTOR translation
2006
Investigador Principal: María de la Luz Montesinos Gutiérrez
Centro de investigación o Institución: Facultad de Medicina. Universidad de Sevilla
más información
sobre Dendritic alterations in Down's Syndrome: the role of the pathway regulating local mTOR translation
-
Molecular foundations of the human ectodermic dysplasia syndrome
2006
Investigador Principal: Paloma Pérez Sánchez
Centro de investigación o Institución: Instituto de Biomedicina de Valencia. CSIC.
más información
sobre Molecular foundations of the human ectodermic dysplasia syndrome
-
Study of the role of the epigenetic mechanisms in the Fanconi Anaemia cancer tendency phenotype
2006
Investigador Principal: Carlos Pipaón González
Centro de investigación o Institución: Hospital Universitario Marqués de Valdecilla. Universidad de Cantabria. Santander.
más información
sobre Study of the role of the epigenetic mechanisms in the Fanconi Anaemia cancer tendency phenotype
-
Molecular analysis of the Ellis-van Creveld Syndrome in the EVC3 epiphyseal growth plate and evaluation of the BBS-EvC connection
2006
Investigador Principal: Víctor Luis Ruiz Pérez
Centro de investigación o Institución: Instituto de Investigaciones Biomédicas "Alberto Sols". CSIC-Universidad Autónoma de Madrid.
más información
sobre Molecular analysis of the Ellis-van Creveld Syndrome in the EVC3 epiphyseal growth plate and evaluation of the BBS-EvC connection
-
Study of the molecular foundations of congenital malformations: cardiovascular, oculofacial and skeletal
2006
Investigador Principal: María José Trujillo Tiebas
Centro de investigación o Institución: Fundación Jiménez Díaz. Madrid
más información
sobre Study of the molecular foundations of congenital malformations: cardiovascular, oculofacial and skeletal